Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Dutch Gold Resources, Inc.

Market Cap 743K 649K 601K 561K 1.05M 70.24M 1.06M 7.14M 2.78M 34.54M 2.79M 2.73M 120M P/E 2010
-1x
P/E 2011 -0.19x
Enterprise Value 4.1M 3.58M 3.31M 3.09M 5.81M 388M 5.85M 39.39M 15.33M 191M 15.4M 15.06M 662M EV / Sales 2010
-
EV / Sales 2011 -
Free-Float
99.74%
Yield 2010 *
-
Yield 2011 -
Manager TitleAgeSince
Chief Executive Officer 74 2002-02-10
Corporate Secretary 61 2010-08-02
Director TitleAgeSince
Chairman 74 2002-02-10
Director/Board Member 61 2001-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 3.5K
-1.92%-3.78%+74.82%+141.52% 108B
+0.11%-2.88%+37.87%+239.89% 83.43B
+1.16%-3.04%+97.43%+163.51% 67.25B
+4.67%-0.55%+40.58%+206.51% 55.3B
-5.11%-6.57%+79.72%+280.54% 43.6B
+0.84%-2.51%+75.42%+514.85% 31.42B
-2.74%-3.19%+3.72%+67.64% 21.23B
-0.08%-0.40%+19.68%+88.37% 18.22B
-0.23%-6.38%+96.29%+506.60% 18.07B
Average -0.33%-0.56%+58.39%+245.49% 44.67B
Weighted average by Cap. -0.27%-2.23%+62.85%+220.16%

Financials

2010 2011
Net sales - -
Net income -3.7M -3.23M -2.99M -2.79M -5.24M -349M -5.28M -35.52M -13.82M -172M -13.89M -13.58M -597M -4.58M -4M -3.7M -3.46M -6.49M -433M -6.54M -44M -17.12M -213M -17.2M -16.83M -739M
Net Debt -160K -139K -129K -120K -226K -15.08M -228K -1.53M -596K -7.42M -599K -586K -25.76M 3.36M 2.93M 2.71M 2.53M 4.76M 317M 4.79M 32.25M 12.55M 156M 12.61M 12.33M 542M
Logo Dutch Gold Resources, Inc.
Dutch Gold Resources, Inc. is a provider of educational services to consumers and healthcare providers on the use of Cannabidiol (CBD). The Company provides forums for patients and doctors to learn, and to talk with one another about the use of CBD's. The Company's products include the Medical Endocannabinoid Manual, an around 400 page medical text for healthcare practitioners. Medical Endocannabinoid Manual provides information for pharmacological use for substantiated and recognized disease entities and disorders, including dosage guidelines, descriptions of medical cannabis strains, contraindications and adverse reactions, use with prescription and over the counter medications, and employment with alternative and complementary medicine. The Medical Endocannabinoid Manual contains around 10 quick-reference monochromatic charts and research references for comprehension of the physiological basis for use of cannabinoids, making it ideal for both clinical and educational reference.
Employees
-
Sector
Gold
  1. Stock Market
  2. Stocks
  3. DGRI Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!